Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow GUIDED THERAPEUTICS INC

Get SEC filing alerts via email and in your feed for GUIDED THERAPEUTICS INC

GTHP

GUIDED THERAPEUTICS INC

About GUIDED THERAPEUTICS INC

Guided Therapeutics, Inc. develops innovative medical devices focused on non-invasive cancer detection, primarily through the LuViva Advanced Cervical Scan. The device uses biophotonics technology to identify cervical cancers and precancers painlessly at the point of care. The company targets global markets, including developing countries and developed nations, emphasizing regulatory approval, strategic partnerships, and international distribution to improve early cancer detection and reduce healthcare costs.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from GUIDED THERAPEUTICS INC

1
1
GUIDED THERAPEUTICS INC Guided Therapeutics Reports $1.0 Million Net Loss in Q1 2026, Focuses on LuViva Device Commercialization

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
GUIDED THERAPEUTICS INC Guided Therapeutics Reports Revenue Surge to $766,948 for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
GUIDED THERAPEUTICS INC Guided Therapeutics Reports Revenue Growth and Increased Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
GUIDED THERAPEUTICS INC Guided Therapeutics Reports Revenue Growth to $117,462 but Faces Increased Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
GUIDED THERAPEUTICS INC Guided Therapeutics Reports $462,742 Net Loss in Q1 2025, Focuses on LuViva Device Commercialization

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
GUIDED THERAPEUTICS INC Guided Therapeutics Reports Net Loss, Reduced Expenses, and Increased Revenue Commitments in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments